Cost-effectiveness of human papillomavirus vaccination in Germany.

Damm, Oliver; Horn, Johannes; Mikolajczyk, Rafael T; Kretzschmar, Mirjam E E; Kaufmann, Andreas M; Deleré, Yvonne; Ultsch, Bernhard; Wichmann, Ole; Krämer, Alexander; Greiner, Wolfgang

dc.contributor.author	Damm, Oliver
dc.contributor.author	Horn, Johannes
dc.contributor.author	Mikolajczyk, Rafael T
dc.contributor.author	Kretzschmar, Mirjam E E
dc.contributor.author	Kaufmann, Andreas M
dc.contributor.author	Deleré, Yvonne
dc.contributor.author	Ultsch, Bernhard
dc.contributor.author	Wichmann, Ole
dc.contributor.author	Krämer, Alexander
dc.contributor.author	Greiner, Wolfgang
dc.date.accessioned	2017-09-22T09:49:34Z
dc.date.available	2017-09-22T09:49:34Z
dc.date.issued	2017
dc.identifier.citation	Cost-effectiveness of human papillomavirus vaccination in Germany. 2017, 15:18 Cost Eff Resour Alloc	en
dc.identifier.issn	1478-7547
dc.identifier.pmid	28878573
dc.identifier.doi	10.1186/s12962-017-0080-9
dc.identifier.uri	http://hdl.handle.net/10033/621117
dc.description.abstract	The aim of this study was to assess the cost-effectiveness of human papillomavirus (HPV) vaccination in addition to the current cervical cancer screening programme in Germany using a dynamic transmission model.
dc.language.iso	en	en
dc.rights.uri	http://creativecommons.org/licenses/by-nc-sa/4.0/	*
dc.title	Cost-effectiveness of human papillomavirus vaccination in Germany.	en
dc.type	Article	en
dc.contributor.department	Hemholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7, 38124 Braunschweig, Germany.	en
dc.identifier.journal	Cost effectiveness and resource allocation : C/E	en
refterms.dateFOA	2018-06-13T07:38:45Z
html.description.abstract	The aim of this study was to assess the cost-effectiveness of human papillomavirus (HPV) vaccination in addition to the current cervical cancer screening programme in Germany using a dynamic transmission model.